HomeGDTC • NASDAQ
add
CytoMed Therapeutics Ltd
Previous close
$2.43
Day range
$2.32 - $2.49
Year range
$1.65 - $4.05
Market cap
27.89M USD
Avg Volume
139.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (SGD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 225.34K | 101.04% |
Operating expense | 1.23M | 31.84% |
Net income | -1.12M | -106.15% |
Net profit margin | -497.85 | -2.54% |
Earnings per share | — | — |
EBITDA | -929.20K | -25.63% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SGD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.85M | -58.16% |
Total assets | 8.36M | -23.40% |
Total liabilities | 1.13M | 51.55% |
Total equity | 7.22M | — |
Shares outstanding | 11.54M | — |
Price to book | 3.92 | — |
Return on assets | -30.48% | — |
Return on capital | -33.03% | — |
Cash Flow
Net change in cash
| (SGD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.12M | -106.15% |
Cash from operations | -799.58K | -38.35% |
Cash from investing | -11.28K | 98.80% |
Cash from financing | -17.44K | -18.04% |
Net change in cash | -921.04K | 38.62% |
Free cash flow | -500.06K | 43.76% |
About
Founded
2018
Website
Employees
43
